Benchmark International Advises on the Sale of Advanced Renal Care, Inc. to Fresenius Medical Care of North America
Benchmark International has successfully facilitated the transaction between Advanced Renal Care, Inc. and Fresenius Medical Care of North America. Fresenius Medical Care of North America is one of the largest dialysis providers in north America. Advanced Renal Care, Inc. is a dialysis provider in Tampa, Florida.
Dr. Stanley Dennison, CEO and Owner of Advanced Renal Care, Inc. stated, “I would like to thank Benchmark International for their drive, and focus on closing this transaction. This transaction faced difficulties at times. The Benchmark International team always stayed focused, and did not falter in the time of need.”
“We are truly excited to have acquired Advanced Renal Care, Inc. This presents a fantastic opportunity for Fresenius Medical Care to treat new patients,” stated Erik Lyesiuk, Senior Director of Mergers & Acquisitions of Fresenius Medical Care.
Benchmark International Director Dara Shareef stated, “We would like to congratulate both Advanced Renal Care, Inc. and Fresenius Medical Care of North America. This acquisition is a terrific strategic move for Fresenius Medical Care, allowing them to enter the Tampa Bay market. The buyer truly valued our clients location and access to major hospitals in the area. We feel this deal was win-win for both sides and wish all the best in the future.”
ABOUT BENCHMARK INTERNATIONAL
Benchmark International’s global offices provide business owners in the middle market and lower middle market with creative, value-maximizing solutions for growing and exiting their businesses. To date, Benchmark International has handled engagements in excess of $5B across 30 industries worldwide. With decades of global M&A experience, Benchmark International’s deal teams, working from 13 offices across the world, have assisted hundreds of owners achieve their personal objectives and ensure the continued growth of their businesses.
Call Benchmark International today if you are interested in an exit or growth strategy or if you are interested in acquiring.
US HQ CONTACT:
Sam Smoot, Director
UK HQ CONTACT:
0161 696 0000